Research Efforts and Grant Opportunities
Our Research efforts are designed to support the advancement of publishable clinical research trials that measure and verify the effects of Fascial Counterstrain when used to treat various health conditions.
Research
Our Research
Our first research study was designed to explore Fascial Counterstrain and its impact on traumatic stress symptoms in First Responders and Veterans.
We are in the final stages of reviewing our paper as we prepare to share it with a peer reviewed journal in hopes of getting our research published.
Research Grants
Our long term goal is to be able to offer $10,000 grants to researchers conducting trials to measure and verify the effects of Fascial Counterstrain and its effects when used to treat health conditions in the body.
Our hope is to offer our research grant to independent researchers by 2029.
Independent Research
We aimed to provide a proof of concept study showing that Fascial Counterstrain can be an effective physical medicine modality to reduce the symptoms of posttraumatic stress.
Our Research
“Can Fascial Counterstrain effectively treat symptoms of posttraumatic stress disorder and its comorbidities?”
The Bridge Back Project's founding research team spent 3 years discussing, winnowing, and finalizing the ideas and protocol that would become our first clinical research trial study.
The study ran from January 2020 to October 2021 and we hope to publish our research findings in a peer-reviewed journal soon.
Any time you see us mention FCS as an application for PTSD, we are referring to work done with patients during our study. Fascial Counterstrain it is not an approved treatment for PTSD at this time. It is considered an experimental treatment and more research is needed to explore and determine efficacy.
Current Status: So close!
Our team is working on the final stages of the research paper in preparation for submitting our findings to the peer review process. We are hopeful that we will be able to publish in the summer or fall of 2024. Our team has worked diligently to provide a transparent, comprehensive report on our findings.
Once we publish, we will invest in open access fees to make our research available to everyone and share what we learned with great enthusiasm.
If you want to support us across the finish line of this 5 years effort and help us cover open access fees to make our work available to everyone ($3,000) please consider making a donation today.
Future Research
Our Research Team is continually discussing and brainstorming ideas for future research. At this time, we hope to embark on our next study as early as 2028. Regardless of the preparation timeline required, we remain eager to explore the applications of Fascial Counterstrain to treat life-impacting health conditions over the decades to come.
We would like to use imaging and labs to provide more concrete evidence to support our theories of how Fascial Counterstrain impacts the body’s physiological processes.
Acknowledgements
We’d like to acknowledge our Fascial Counterstrain practitioner team - Dr. Holly Christy (ND, LAEMP, CACI, JSCCI), Brian Tuckey (PT, OCS, CSCI), Willy Cherry (PT), Shannon Arndt (MSPT, JSCC), Dr. Rachel Harmon (ND, LAc); our psychologist, Dr. Sharon Johnson; our co-authors - Brian Tuckey (innovator of Fascial Counterstrain) and Dr. Meena Vythilingam (MD, Director, Center for Health Innovation at U.S. Department of Health and Human Services (HHS)); and our statisticians at Mountain-Whisper-Light Statistics and Data Science, Dr. Miljacic (MS, PhD) and Dr. Polissar (PhD).
Research Grant Program
What will the Research Grant Program look like?
The Bridge Back Project will work towards offering $5,000-$10,000 in funding each year to independent research groups that investigate the effect Fascial Counterstrain can have to treat a wide variety of conditions and ailments. We hope to offer our first research grants as early as 2027.
To keep up to date on our own research progress as well as receive news about the Research Grant Program, subscribe to our newsletter.
